Equilium en es it fr

Equilium Brand names, Equilium Analogs

Equilium Brand Names Mixture

  • No information avaliable

Equilium Chemical_Formula


Equilium RX_link

No information avaliable

Equilium fda sheet

Equilium msds (material safety sheet)

Equilium Synthesis Reference

No information avaliable

Equilium Molecular Weight

309.469 g/mol

Equilium Melting Point

< 25 oC

Equilium H2O Solubility

Soluble as HCl salt

Equilium State


Equilium LogP


Equilium Dosage Forms

Tablets (oral, 1 mg)

Equilium Indication

Used for the symptomatic treatment of parkinsonism.

Equilium Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Equilium Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Equilium side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Equilium Patient Information

Equilium Organisms Affected

Humans and other mammals